Skip to main content
Fulltext search
Apply
Home
About
Overview
Directors & management
Services
Platforms
All platforms
LentiVector
®
platform
Adeno-Associated Virus (AAV) platform
Adenovirus expertise
TRiP System
TM
LentiStable
TM
Process development
Analytics
Commercially approved vectors
Automation and System Integration
Pipeline
ESG
Our ESG Mission and Responsible Business Strategy
Integrity and Ethics
People
Community
Environment
Innovation
Supply Chain
Investors
Investors homepage
Results, reports, presentations & webcasts
Regulatory news
Shareholder meetings, circulars & prospectuses
Financial calendar
Corporate governance
Board committees
Investor contacts
Analyst coverage and research reports
Share price information
Registrars
Warning to shareholders
News & events
Press releases
Events
Multimedia
Media contact details
Careers
Search
Contact
Contact form
Addresses
Fulltext search
Apply
2023 Preliminary Results Announcement
twitter
linkedin
mail
April 2023
Guidance:
Q2 2023
Start date:
Friday, February 11, 2022 - 19:30
Close
